Despite optimal wound care, some wounds are difficult to heal. This randomized controlled study provides evidence for the use of dermal substitute for the management of diabetic foot ulcers.
The differences in outcomes were clinically significant.
In Brief:
This study was designed to gain experience in the use of Dermagraft, a human fibroblast-derived dermal substitute, for the treatment of nonhealing diabetic foot ulcers.
